SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Vermillion, Inc. – IPO: ‘S-1MEF’ on 9/29/00

On:  Friday, 9/29/00, at 8:47am ET   ·   Effective:  9/29/00   ·   Accession #:  912057-0-43082   ·   File #s:  333-32812, 333-46902

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 9/29/00  Vermillion, Inc.                  S-1MEF      9/29/00    3:12K                                    Merrill Corp/FA

Initial Public Offering (IPO):  Registration of Additional Securities   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1MEF      Registration of Additional Securities                  4     23K 
 2: EX-5.1      Opinion re: Legality                                   1      8K 
 3: EX-23.1     Consent of Experts or Counsel                          1      5K 


S-1MEF   —   Registration of Additional Securities
Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
2Item 16.(a). Exhibits and financial statements schedules
S-1MEF1st Page of 4TOCTopPreviousNextBottomJust 1st
 

AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON SEPTEMBER 29, 2000 REGISTRATION NO. 333- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------ FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ------------------------ CIPHERGEN BIOSYSTEMS, INC. (Exact name of Registrant as specified in its charter) [Enlarge/Download Table] DELAWARE 8731 33-059-5156 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification Number) 6611 DUMBARTON CIRCLE FREMONT, CA 94555 (510) 505-2100 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) ------------------------ WILLIAM E. RICH, PH.D. PRESIDENT AND CHIEF EXECUTIVE OFFICER CIPHERGEN BIOSYSTEMS, INC. 6611 DUMBARTON CIRCLE FREMONT, CA 94555 (510) 505-2100 (Name, address, including zip code, and telephone number, including area code, of agent for service) ------------------------ COPIES TO: [Download Table] MICHAEL J. O'DONNELL, ESQ. JOHN MONTGOMERY, ESQ. RICHARD L. PICHENY, ESQ. BROBECK, PHLEGER & HARRISON LLP WILSON SONSINI GOODRICH & ROSATI TWO EMBARCADERO PLACE PROFESSIONAL CORPORATION 2200 GENG ROAD 650 PAGE MILL ROAD PALO ALTO, CA 94303 PALO ALTO, CA 94304 (650) 424-0160 (650) 493-9300 ------------------------ APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: As soon as practicable after the effective date of this Registration Statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. / / If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. /X/ 333-32812 If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. / / If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. / / If delivery of the prospectus is expected to be made pursuant to Rule 434, check the following box. / / CALCULATION OF REGISTRATION FEE [Enlarge/Download Table] AMOUNT TO BE PROPOSED MAXIMUM AMOUNT OF TITLE OF EACH CLASS OF SECURITIES TO BE REGISTERED REGISTERED(1) AGGREGATE OFFERING PRICE REGISTRATION FEE Common Stock $0.001 per share............................. 575,000 $9,200,000 $2,429(2) (1) Includes 75,000 shares subject to an over-allotment option to be granted to the Underwriters. (2) The Company previously registered an aggregate of $92,000,000 worth of Common Stock on a Registration Statement on Form S-1 (File No. 333-32812), for which a filing fee of $24,288 was previously paid on the filing of such Registration Statement. The Registrant has instructed a bank to transmit by wire transfer the filing fee to the Securities and Exchange Commission. The Registrant will not revoke such instruction, and it has sufficient funds in such account to cover the amount of the registration fee. -------------------------------------------------------------------------------- --------------------------------------------------------------------------------
S-1MEF2nd Page of 4TOC1stPreviousNextBottomJust 2nd
INCORPORATION BY REFERENCE This Registration Statement on Form S-1 is being filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended. The contents of the Registration Statement on Form S-1 (Commission File No. 333-32812) filed by Ciphergen Biosystems, Inc. with the Securities and Exchange Commission as declared effective on September 28, 2000, are incorporated herein by reference. EXHIBITS The following exhibits are filed as part of this Registration Statement: Item 16.(a) Exhibits and financial statements schedules [Download Table] EXHIBIT NUMBER DESCRIPTION --------------------- ----------- 5.1 Opinion of Wilson Sonsini Goodrich & Rosati, P.C., as to the legality of the securities 23.1 Consent of PricewaterhouseCoopers LLP, Independent Accountants 23.2 Consent of Wilson Sonsini Goodrich & Rosati, P.C. (included in Exhibit 5.1) All other exhibits in the prior registration statement are incorporated by reference herein. II-1
S-1MEF3rd Page of 4TOC1stPreviousNextBottomJust 3rd
SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Fremont, California, on the 28th day of September 2000. [Download Table] CIPHERGEN BIOSYSTEMS, INC. By: /s/ WILLIAM E. RICH ----------------------------------------- William E. Rich PRESIDENT AND CHIEF EXECUTIVE OFFICER Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated: [Enlarge/Download Table] SIGNATURE TITLE DATE --------- ----- ---- /s/ WILLIAM E. RICH President and Chief Executive ------------------------------------ Officer, and Director September 28, 2000 William E. Rich (PRINCIPAL EXECUTIVE OFFICER) /s/ MATTHEW J. HOGAN ------------------------------------ Chief Financial Officer September 28, 2000 Matthew J. Hogan (PRINCIPAL FINANCIAL OFFICER) * ------------------------------------ Corporate Controller September 28, 2000 Daniel M. Caserza (PRINCIPAL ACCOUNTING OFFICER) * ------------------------------------ Director September 28, 2000 John A. Young * ------------------------------------ Director September 28, 2000 Michael J. Callaghan * ------------------------------------ Director September 28, 2000 Barbara J. Dalton * ------------------------------------ Director September 28, 2000 Jean-Francois Formela * ------------------------------------ Director September 28, 2000 William R. Green * ------------------------------------ Director September 28, 2000 James L. Rathmann * ------------------------------------ Director September 28, 2000 Daniel Vapnek * Pursuant to Power of Attorney previously filed with the Securities and Exchange Commission with the Registration Statement on Form S-1 (File No. 333-32812) and incorporated herein by reference. [Download Table] /s/ WILLIAM E. RICH ------------------------------------ William E. Rich ATTORNEY-IN-FACT II-2
S-1MEFLast Page of 4TOC1stPreviousNextBottomJust 4th
INDEX TO EXHIBITS The following exhibits are filed as part of this Registration Statement: [Enlarge/Download Table] EXHIBITS --------------------- 5.1 Opinion of Wilson Sonsini Goodrich & Rosati, P.C., as to the legality of the securities 23.1 Consent of PricewaterhouseCoopers LLP, Independent Accountants 23.2 Consent of Wilson Sonsini Goodrich & Rosati, P.C. (included in Exhibit 5.1) All other exhibits in the prior registration statement are incorporated by reference herein.

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘S-1MEF’ Filing    Date First  Last      Other Filings
Filed on / Effective on:9/29/001424B1
9/28/0023S-1/A
 List all Filings 
Top
Filing Submission 0000912057-00-043082   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 10:32:13.0am ET